Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501065 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antibiotics for Outpatient Urethral Bulking
A Phase 4 study, sponsored by University of Miami.
- Not yet
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT07501065 is a Phase 4 study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 150 participants.
The verdict
NCT07501065, a Phase 4 study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether taking prophylactic (preventative) antibiotics at the time of standard of care clinic-based urethral bulking reduces the risk of post-procedural urinary tract infection (UTI).
Interventions
- DRUG Bactrim (800/160 mg) or Macrobid (100mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07501065
The ClinicalTrials.gov registry entry for NCT07501065 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bactrim (800/160 mg) or Macrobid (100mg) is the first listed.
NCT07501065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07501065 about?
NCT07501065 is a clinical study titled "Prophylactic Antibiotics for Outpatient Urethral Bulking". The purpose of this study is to evaluate whether taking prophylactic (preventative) antibiotics at the time of standard of care clinic-based urethral bulking reduces the risk of post-procedural urinary tract infection (UTI).
What is the current status of trial NCT07501065?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2026-06. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07501065?
The interventions under investigation include: Bactrim (800/160 mg) or Macrobid (100mg) (DRUG).
Who is sponsoring clinical trial NCT07501065?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.